[TFG] Advancing Eye Care Series   Jaclyn Garlich

Advancing Eye Care Series

1. Dr Jaclyn Garlich Sheds Light on Demodex Blepharitis

Red, irritated eyelids? It might not be allergies or dry eye disease (DED)—it could be Demodex blepharitis, and it’s more common than you think, affecting 57.7% of US patients.

In this episode of the Advancing Eye Care Series, brought to you in conjunction with Who Wants to be an Eyecare Millionaire, expert optometrist Jaclyn Garlich (US) breaks down the warning signs, proper diagnosis and treatment options, including her experience with lotilaner ophthalmic solution 0.25%, the first and only US Food and Drug Administration-approved treatment for the disease. Watch now and make sure Demodex blepharitis isn’t slipping through the cracks in your practice!

2. Breaking Down Glaucoma with Dr. Mitch Ibach

Ever wish you had a comprehensive roadmap for mastering modern glaucoma? Well, Mitch Ibach, OD, FAAO, (US) is here to give the full rundown in this episode of the Advancing Eye Care Series, brought to you in conjunction with Who Wants to be an Eyecare Millionaire.

From the latest innovations to patient care strategies you can apply right now, Dr. Ibach breaks it all down from A to Z—including his personalized approach to a challenging case that will make you rethink the way you look at the disease. Dive in for new perspectives and actionable tips!

3. Dr. Jessilin Quint on Presbyopia Drops

128 million Americans are living with presbyopia—and as Jessilin Quint, OD, MBA, MS, FAAO (US), says, the disease “is here to stay.”

In this episode of the Advancing Eye Care Series, brought to you in conjunction with Who Wants to be an Eyecare Millionaire, Dr. Quint walks us through the cutting-edge treatment options for presbyopia, including the exciting potential of upcoming presbyopia drops.

Tune in for expert optometric advice on managing presbyopia and keep up with what’s next for presbyopia drops!

4. Managing Ocular Surface Disease with Dr. Damon Dierker

Ocular surface disease isn’t just discomfort—it’s a daily struggle for millions. But what if treatment went beyond just eye drops? In this episode of the Advancing Eye Care Series, brought to you in conjunction with Who Wants to be an Eyecare Millionaire, Damon Dierker, OD, FAAO, (US) explores next-level treatments like neurostimulation—because relief isn’t one-size-fits-all. He also shares a game-changing custom treatment case that redefined what’s possible for a patient. If you’re ready to rethink how you treat OSD, you won’t want to miss this one!

Visit Media MICE’s YouTube channel for the full series, and up your ophthalmic practice knowledge now!

This activity is supported by an unrestricted educational grant from Apellis Pharmaceuticals, Inc., LENZ Therapeutics, Orasis Pharmaceuticals, Tarsus Pharmaceuticals, Inc., Topcon Healthcare, Inc., and Viatris, Inc.

Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments